Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines

Biochem Biophys Res Commun. 1988 Apr 15;152(1):237-42. doi: 10.1016/s0006-291x(88)80705-8.

Abstract

Since it is important the availability of a specific marker for interferon induction in vivo, we investigated the effect of different recombinant interferons and various cytokines on indoleamine 2,3-dioxygenase activity. Although with different magnitude, recombinant interferon-alpha A/D (Bgl II) hybrid, interferon-gamma and tumor necrosis factor, all increase the activity of this enzyme, whereas interleukin-1, recombinant interferon-alpha A and interferon-alpha D do not induce this activity in mice lung tissue. Dexamethasone is able to inhibit indoleamine 2,3-dioxygenase induction by lipopolysaccharide or by interferon-alpha A/D but it fails to prevent the induction by interferon-gamma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dexamethasone / pharmacology
  • Enzyme Induction
  • Ibuprofen / pharmacology
  • Interferon Type I / pharmacology*
  • Interferon-gamma / pharmacology*
  • Interleukin-1 / pharmacology*
  • Kinetics
  • Lipopolysaccharides / pharmacology*
  • Lung / drug effects
  • Lung / enzymology*
  • Male
  • Mice
  • Oxygenases / biosynthesis*
  • Recombinant Proteins / pharmacology*
  • Tryptophan Oxygenase
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Interferon Type I
  • Interleukin-1
  • Lipopolysaccharides
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • Interferon-gamma
  • Oxygenases
  • Tryptophan Oxygenase
  • Ibuprofen